Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 18 August 2020
Accepted: 21 August 2020
First Online: 19 October 2020
Compliance with ethical standards
:
: JJM reports no conflicts of interest. CDS reports grants and personal fees from Gilead Sciences, during remdesivir studies. Personal fees from AbbVie, grants and personal fees from Janssen-Cilag, MSD, GSK/ViiV, Grants from Lilly and Selinexor, outside remdesivir studies.
